Figure 2From: A decision-analytic approach to define poor prognosis patients: a case study for non-seminomatous germ cell cancer patientsLinear benefit (30%) and non-linear benefit (30%) vs. harm of high dose chemotherapy, with harm defined as 10-year treatment related mortality (2%) or mortality plus morbidity (5%). The arrows indicate the thresholds to define poor prognosis (7% and 17% respectively for linear benefit, 4% and 11% respectively for non-linear benefit).Back to article page